ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Investigating dysbiosis and microbial treatment strategies in inflammatory bowel disease based on two modified Koch's postulates

Zhao, HanZheng; Zhang, WenHui; Cheng, Die; You, LiuPing; Huang, YueNan*; Lu, YanJie*哈尔滨医科大学
Frontiers in Medicine2022-11-10DOI: 10.3389/fmed.2022.1023896
3被引7阅读
引用收藏
分享

摘要

Inflammatory bowel disease (IBD) is a chronic non-specific inflammatory disease that occurs in the intestinal tract. It is mainly divided into two subtypes, i.e., the Crohn's disease (CD) and ulcerative colitis (UC). At present, its pathogenesis has not been fully elucidated, but it has been generally believed that the environment, immune disorders, genetic susceptibility, and intestinal microbes are the main factors for the disease pathogenesis. With the development of the sequencing technology, microbial factors have received more and more attention. The gut microbiota is in a state of precise balance with the host, in which the host immune system is tolerant to immunogenic antigens produced by gut commensal microbes. In IBD patients, changes in the balance between pathogenic microorganisms and commensal microbes lead to changes in the composition and diversity of gut microbes, and the balance between microorganisms and the host would be disrupted. This new state is defined as dysbiosis. It has been confirmed, in both clinical and experimental settings, that dysbiosis plays an important role in the occurrence and development of IBD, but the causal relationship between dysbiosis and inflammation has not been elucidated. On the other hand, as a classic research method for pathogen identification, the Koch's postulates sets the standard for verifying the role of pathogens in disease. With the further acknowledgment of the disease pathogenesis, it is realized that the traditional Koch's postulates is not applicable to the etiology research (determination) of infectious diseases. Thus, many researchers have carried out more comprehensive and complex elaboration of Koch's postulates to help people better understand and explain disease pathogenesis through the improved Koch's postulates. Therefore, focusing on the new perspective of the improved Koch's postulates is of great significance for deeply understanding the relationship between dysbiosis and IBD. This article has reviewed the studies on dysbiosis in IBD, the use of microbial agents in the treatment of IBD, and their relationship to the modified Koch's postulates.

学科与关键词

关键词
Koch's postulatesinflammatory bowel diseasedysbiosismicrobial treatmentgut microbiome
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Medicine
发表日期
2022-11-10
卷期
第 9 卷
页码
1023896
DOI
10.3389/fmed.2022.1023896
期刊等级
3区
成果收录
SCIE
资助标注
Natural Science Foundation of Hebei Province, China; Technology Innovation Guidance Project-Science and Technology Work Conference of Hebei Provincial Department of Science and Technology; Key Subjects at Colleges and Universities of Hebei Province; [H2020406008]

作者

  • Z

    Zhao, HanZheng (第一作者)

    2 · harbin med univ

  • Z

    Zhang, WenHui

    harbin med univ

查看全部 6 位作者收起作者
  • C

    Cheng, Die

    chengde med coll

  • Y

    You, LiuPing

    2 · harbin med univ

  • H

    Huang, YueNan (通讯)

    2 · harbin med univ

  • L

    Lu, YanJie (通讯)

    chengde med coll

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417